Preclinical Case Study - Assessing the Safety of Novel Therapeutics for Pediatric Indications
June 2019
Pharma Tech Outlook Top 10 CROs
Gut Health Connections to Overall Health - Part 2 of a 2-part series
Gut Health Connections to Overall Health (part 2 of 2)
In part 1 of this series, we discussed how gut bacteria, or the microbiota, affect your health, from metabolism to mood, and contribute to a number of chronic diseases.
Applying the 3Rs by Implementing Social Housing Configuration
Quantitation of a PEGylated Human Parathyroid Hormone (1-34) Analog in Rat Plasma Using a Hybrid Immunoaffinity Bottom-Up LC-MS/MS Assay
The Application of Light-Absorbing Photostabilizers for the Determination of Protoporphyrin IX in Human Plasma by LC-MS/MS
Overcoming Recovery Challenges in Hemolyzed Samples for the Determination of Propafenone and 5-Hydroxy Propafenone by LC-MS/MS
Up Close and Personal with Mike Broadhurst
Mike Broadhurst joined the Altasciences’ team in 2018.
Gut Health Connections to Overall Health - Part 1 of a 2-part series
“All Disease Begins in The Gut.” – Hippocrates
Research increasingly supports the idea that your gut bacteria are tied to your probability of intestinal disorders and other conditions, like diabetes, obesity, depression, and colon cancer. In this issue of the Altasciences blog, we offer an oversight of the research into how they are linked.
We have retained the services of Algorithme Pharma (now Altasciences) since 2011 to perform a series of studies ranging from Phase I to Phase III. Consequently, the study populations requested varied from healthy volunteers to populations with a specific disorder such as healthy volunteers suffering from common cold and persons with type 1 or type 2 diabetes (to address our needs). Although Algorithme Pharma (now Altasciences) has traditionally focused on early stage clinical research, they have clearly shown their ability to recruit for and conduct Phase II and Phase III studies.